GlassScriptPhysician profile
Michael H Tunick
NPI 1023100542
$845.99
in general payments reported to CMS, 2019-2025
18 companies · $14.63 in 2025
The $14.63 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $75.52 · 2021: $170 · 2022: $186 · 2023: $164 · 2024: $29.61 · 2025: $14.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $298.77 | 2021-2024 | Vraylar |
| Novo Nordisk INC | $117.32 | 2019-2022 | |
| Pfizer INC. | $70.10 | 2019-2021 | |
| Abbott Laboratories | $58.67 | 2020-2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $49.32 | 2021-2022 | |
| Amgen INC. | $37.33 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.00 | 2019-2022 | |
| Lilly USA, LLC | $26.35 | 2020-2022 | |
| Nevro Corp. | $23.66 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.88 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.84 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.74 | 2022 | |
| Allergan, INC. | $14.33 | 2020 | |
| Si-Bone, INC. | $14.27 | 2019 | |
| Glaxosmithkline, LLC. | $13.22 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12.91 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.84 | 2021 | |
| Neuronetics, INC. | $10.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tunick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.